Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Eleni M. Gamvroulas; Patricia Jeppson; Mei Wei

doi:10.12659/AJCR.949828

24 October 2025 : Case report USA

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Unusual clinical course, Adverse events of drug therapy

Eleni M. Gamvroulas^{BDEF 1*}, Patricia Jeppson^{E 1}, Mei Wei

^{ADEF 2}

DOI: 10.12659/AJCR.949828

Am J Case Rep 2025; 26:e949828

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 5 A 38-year-old woman with infusion site extravasation injury following intravenous treatment with TDM1. At 20 days after initial insult, the erythema continued to decrease. The scabbing is markedly improved, with only a small focus remaining.

Back to the Article

Medical Management of an Infusion Site Extravasation Injury After Peripheral Intravenous Infusion of Ado-Trastuzumab Emtansine in a 38-Year-Old Woman With Breast Cancer: A Case Report

Your Privacy